Cell proliferation kinetics and nuclear morphology in endometrial cancer under progesteron treatment.
Cell proliferation kinetics by using the double labeling with 3HTdR--14CTdR, and nuclear morphology were studied in 20 patients with endometrial cancer who were given progesteron as a preliminary therapeutic measure. Results of these studies indicate that we have to face the fact that in all histological types of endometrial cancer considerable variations in the amount of tumor cells undergoing secretory conversion occur due to the primary heterogeneity of the tumor cell population.
D002454:Cell Differentiation; D002455:Cell Division; D002467:Cell Nucleus / Q000473:pathology; D005260:Female; D006801:Humans; D007700:Kinetics; D009376:Neoplasms, Hormone-Dependent / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D011374:Progesterone / Q000627:therapeutic use*; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*
D011374:Progesterone